Dylan is an impact entrepreneur with a track record of building socially conscious technology companies in areas such as civil justice, local democracy, and now mental healthcare. He currently serves as the Founder and CEO of Mindbloom, a mental health and wellbeing brand helping people achieve personal and clinical breakthroughs with at-home, clinician-prescribed psychedelic therapies, beginning with ketamine. Dylan previously served as Co-founder and Chief Growth Officer at Mighty ($100M+ raised) and Co-founder and Head of Marketing at Voter's Friend (acquired by Democracy.com). Learn more about Mindbloom at mindbloom.com.
[0:59] - How Dylan's personal story directed him towards positive technology companies
[7:12] - Examining the effects of different psychedelics on the human brain
[13:50] - Transitioning from recreational psychedelic usage to psychedelic research
[18:16] - Preparation, navigation, and integration for psychedelic experiences
[28:32] - Dealing with the reservations of mental and emotional change
[33:56] - Overcoming the access barrier for psychedelics
[39:16] - Leveraging the shift to telemedicine services to grow Mindbloom
[45:10] - Towards mainstream psychedelic usage with clinical trials
---